Company Encyclopedia
View More
name
Tilray Brands
TLRY.US
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products.
4.668 T
TLRY.USMarket value -Rank by Market Cap -/-

Financial Score

16/12/2025 Update
D
PharmaceuticalsIndustry
Industry Ranking131/183
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-85.59%E
    • Profit Margin-258.54%E
    • Gross Margin27.43%C
  • Growth ScoreD
    • Revenue YoY2.31%C
    • Net Profit YoY-910.20%E
    • Total Assets YoY-51.13%E
    • Net Assets YoY-56.35%E
  • Cash ScoreC
    • Cash Flow Margin-38.68%D
    • OCF YoY2.31%C
  • Operating ScoreD
    • Turnover0.26D
  • Debt ScoreB
    • Gearing Ratio26.98%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Pot stocks keep blazing, after Trump says he's 'very strongly' looking at rescheduling cannabis

    Cannabis stocks surged after President Trump announced he is "very strongly" considering rescheduling cannabis, potentially easing regulations. This move could reclassify cannabis from Schedule I to Schedule III, allowing more research. Stocks like Tilray and Canopy Growth saw significant gains. The White House is discussing this reclassification, but no final decision has been made. Investors are hopeful for federal easing as more U.S. states legalize cannabis, despite past legislative stalls.

    Dow Jones·
    US
    CGC
    +12.05%
    US
    TLRY
    +21.32%
    Dow Jones·
    US
    CGC
    +12.05%
    US
    TLRY
    +21.32%

    BUZZ-Cannabis stocks rise after Trumps considers executive order to reclassify marijuana

    Cannabis stocks surged after President Trump announced he might sign an executive order to reclassify marijuana as a less dangerous drug. This potential reclassification could ease criminal penalties and reshape the industry by lowering tax burdens and facilitating funding. Shares of companies like Canopy Growth, Cronos Group, SNDL, Aurora Cannabis, and Tilray Brands saw significant increases, with Tilray jumping 21.6%. The stocks remain above their levels from last week when the reclassification news first emerged.

    Reuters·
    US
    TLRY
    +21.32%
    US
    SNDL
    +4.69%
    US
    ACB
    +5.57%
    Reuters·
    US
    TLRY
    +21.32%
    US
    SNDL
    +4.69%
    US
    ACB
    +5.57%

    Is Tilray Brands Inc Gaining or Losing Market Support?

    Tilray Brands Inc's short interest has surged 981.72%, with 95.84% of shares sold short. This indicates bearish market sentiment, as it exceeds the peer average of 11.33%. Short interest can signal potential stock price movements, with increased shorting possibly being bullish. Traders should note the high short interest compared to peers.

    benzinga_article·
    US
    TLRY
    +21.32%
    benzinga_article·
    US
    TLRY
    +21.32%

    Trending | TLRY Plummets 10% on Monday, Some Put options Soar 100%

    On December 15, Eastern Time, Tilray Brands options saw a total of 96126 contracts traded, with calls accounting for 75% and puts making up 24%.

    LB Option·
    US
    TLRY
    +21.32%
    LB Option·
    US
    TLRY
    +21.32%

    Why Tilray stock plunged today

    The legal status of marijuana in the U.S. remains scattered and confusing.

    MSN·
    US
    TLRY
    +21.32%
    MSN·
    US
    TLRY
    +21.32%
    © 2025 Longbridge｜Disclaimer